ARA-290
ARA 290 is a cutting-edge peptide originally developed to mimic the tissue-protective effects of erythropoietin (EPO) without stimulating red blood cell production. It works by targeting the innate repair receptor (IRR), promoting anti-inflammatory and neuroprotective responses throughout the body. ARA 290 has shown significant promise in treating chronic pain, nerve injury, autoimmune conditions, and symptoms associated with small fiber neuropathy, especially in patients with diabetes or sarcoidosis. Its ability to restore tissue homeostasis and modulate immune function makes it a powerful tool for both recovery and long-term wellness.
Benefits of ARA 290:
-
Reduces chronic inflammation
-
Promotes nerve regeneration and repair
-
Improves symptoms of small fiber neuropathy
-
Alleviates neuropathic and chronic pain
-
Supports immune system modulation
-
Enhances tissue healing without increasing red blood cell count
-
May benefit autoimmune and inflammatory conditions
All of our peptides are sourced from FDA-licensed pharmaceutical manufacturers and pharmacies, ensuring the highest standards of quality and safety. Due to the ever-changing FDA regulatory landscape regarding peptides, some of the peptides may not always be available.